How the clinical trials influence update of indications and recommendations? Review article
Article Sidebar
Published:
Sep 30, 2009
Keywords:
clinical trial, class of recommendation, level of evidence
Main Article Content
Abstract
Clinical trials result in new indication for drugs and recommendations in treatment guidelines. Presentation of new data can lead to changes in classes and levels of evidence for recommendations. This article presents in several examples this issue.
Article Details
How to Cite
Grabowski , M. (2009). How the clinical trials influence update of indications and recommendations?. Medycyna Faktow (J EBM), 2(3(4), 80-84. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2652
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Grabowski M., Filipiak K.J.: Evidence Based Medice na przykładzie badań z lekami hipolipemizującymi – 44 pytania i odpowiedzi. Medical Education, Warszawa 2008: 1-81.
2. Heart Protection Study Collaborative Group (writing committee: Collins R., Armitage J., Parish S., Sleight, Peto R.): MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
3. The CURE Trial Investigators. N. Engl. J. Med. 2001; 345: 494-502.
4. Bassand J.P., Hamm C.W., Ardissino D. et al.: The Task Force of Diagnosis and Treatment of Non-ST-segment Elecation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 2007; Jul.; 28(13): 1598-660. Epub 2007; Jun. 14.
5. Anderson J.L., Adams C.D., Antman E.M. et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2007; Aug. 14; 50(7): e1-e157. Erratum in: J. Am. Coll. Cardiol. 2008; Mar. 4; 51(9): 974.
6. Van de Werf F., Bax J., Betriu A. et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart. J. 2008; Dec.; 29(23): 2909-45.
7. Antman E.M., Hand M., Armstrong P.W. et al.: 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2008, Jan. 15; 51(2): 210-47. Review. Erratum in: J. Am. Coll. Cardiol. 2008, Mar. 4; 51(9): 977.
8. Sabatine M.S., Cannon C.P., Gibson C.M. et al.: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New Eng. J. ed.. 2005; 352: 1179-1189.
9. Chen Z.M. et al.: Prezentacja podczas kongresu ACC 2005.
10. Fox K., Garcia M.A., Ardissino D., Buszman P., Camici P.G., Crea F. et al.: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006; 27(11): 1341-1381.
2. Heart Protection Study Collaborative Group (writing committee: Collins R., Armitage J., Parish S., Sleight, Peto R.): MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
3. The CURE Trial Investigators. N. Engl. J. Med. 2001; 345: 494-502.
4. Bassand J.P., Hamm C.W., Ardissino D. et al.: The Task Force of Diagnosis and Treatment of Non-ST-segment Elecation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 2007; Jul.; 28(13): 1598-660. Epub 2007; Jun. 14.
5. Anderson J.L., Adams C.D., Antman E.M. et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2007; Aug. 14; 50(7): e1-e157. Erratum in: J. Am. Coll. Cardiol. 2008; Mar. 4; 51(9): 974.
6. Van de Werf F., Bax J., Betriu A. et al.: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur. Heart. J. 2008; Dec.; 29(23): 2909-45.
7. Antman E.M., Hand M., Armstrong P.W. et al.: 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2008, Jan. 15; 51(2): 210-47. Review. Erratum in: J. Am. Coll. Cardiol. 2008, Mar. 4; 51(9): 977.
8. Sabatine M.S., Cannon C.P., Gibson C.M. et al.: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. New Eng. J. ed.. 2005; 352: 1179-1189.
9. Chen Z.M. et al.: Prezentacja podczas kongresu ACC 2005.
10. Fox K., Garcia M.A., Ardissino D., Buszman P., Camici P.G., Crea F. et al.: Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 2006; 27(11): 1341-1381.